Clinical Trial Update: TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing TIPS plus half-dose donafenib with AHCC for hepatocellular carcinoma with PVTT and PVTT-associated portal hypertension is rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• AHCC (Active Hexose Correlated Compound)
• Donafenib (donafenib)

Snippet

Sponsor: Fei Gao | Conditions: Hepatocellular Carcinoma with PVTT | Phase 2 | Status: RECRUITING